Klapstein Julie D 4

What Happened

• Julie D. Klapstein, a director of Omada Health, was awarded 698 restricted stock units (RSUs) on 2026-04-05. The Form 4 reports an acquisition price of $0.00 for these RSUs (transaction code A — grant/award). The filing lists the reported value as $0 because RSUs are granted with no cash outlay; actual economic value will depend on Omada’s share price when the RSUs settle.

Key Details

• Transaction date: 2026-04-05; Form 4 filed: 2026-04-07 (filed within the standard 2-business-day window).
• Transaction type/code: A (grant/award of RSUs).
• Shares granted: 698 RSUs; reported acquisition price: $0.00; reported cash value on form: $0.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: RSUs were granted under the Issuer’s Non-Employee Director Compensation Program in lieu of retainer fees; each RSU represents the right to one share, with settlement timing per the Program or as elected by the director.

Context

• RSU grants to non-employee directors are a common form of compensation and do not represent an open-market purchase or sale. They typically vest or settle later and convert into common shares based on the company’s stock price at that time.
• This filing is informational and does not, by itself, indicate insider sentiment about the stock since it reflects compensation rather than a discretionary buy or sell.